We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radiation Dose Management Solution for Clinicians and Patients Released

By MedImaging International staff writers
Posted on 28 Dec 2014
A new software portal that provides a broad, comprehensive, and holistic radiation dose management strategy for healthcare providers has been released at Radiological Society of North America Annual Meeting (RSNA) 2014.

The software allows providers to keep track of all imaging radiation to which clinicians and patients are exposed. Dose reduction is becoming more important with increasingly stringent dose management compliance standards and regulations such as Medical Imaging & Technology Alliance (MITA) Smart Dose XR-29 standard.

The DoseWise portal allows personal radiation dose tracking, analysis, and monitoring in a range of diagnostic environments and includes training and instructions for safe use of imaging equipment that minimizes cumulative radiation exposure. Improvements in technology are also expected to allow use of reduce radiation doses. The portal includes a number of Philips services and products including IMR, DoseAware, and ClarityIQ.

The portal was developed by Royal Philips (Amsterdam, the Netherlands). According to Gene Saragnese, executive vice president and CEO of Philips Imaging Systems, "Philips DoseWise Solutions return a measure of control to patient care, arming clinicians and informing patients with the tools, training and insights they need in order to ask the right questions regarding radiation dose."

Related Links:

Philips Healthcare


X-ray Diagnostic System
FDX Visionary-A
Post-Processing Imaging System
DynaCAD Prostate
MRI System
nanoScan MRI 3T/7T
Pocket Fetal Doppler
CONTEC10C/CL

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.